Tianquan pharmaceutical changed the guidance target plate to the Beijing stock exchange

On January 12, Tianquan pharmaceutical, a new third board company, announced that considering the long-term impact caused by the change of national medical reform policy and the company’s future development plan, the company plans to apply for public offering and listing in the Beijing stock exchange, and change the guidance and filing section of initial public offering to the Beijing stock exchange. In view of this, The company submitted the change application materials to Fujian Securities Regulatory Bureau on January 12, 2022.